trending Market Intelligence /marketintelligence/en/news-insights/trending/8U79l7gswr3ebF-k086zYQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

NetScientific shares update on strategic review

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

NetScientific shares update on strategic review

NetScientific PLC provided an update regarding the strategic review of its options, including a possible sale.

The London-based venture capital firm specializing in healthcare technology and digital health said it received indications of interest in a potential acquisition, however, no formal offers have been made as of Dec. 20.

NetScientific added that it expects to have about £3 million pounds in cash resources Dec. 31. It expects to have central costs of about £2 million and to invest up to about £5 million in its portfolio companies, should they fail to raise external finance, in each of 2019 and 2020.

The company may seek additional funding from its shareholders and take material actions, including seeking a delisting, to further reduce costs.

NetScientific's shares currently trade on the Alternative Investment Market of the London Stock Exchange under the symbol NSCI.